XML 103 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues:      
Total net sales $ 2,406,596 $ 2,419,929 $ 2,309,078
Costs and operating expenses:      
Costs and operating expenses 1,010,700 992,564  
Selling and administrative expenses 534,791 536,902 544,363
Research and development expenses 142,955 143,403 132,593
Purchased intangibles amortization 9,693 7,712 6,743
Litigation provision (settlement) (Note 11)   (426) 11,114
Acquired in-process research and development (Note 2)     5,000
Total costs and operating expenses 1,698,139 1,680,155 1,646,880
Operating income 708,457 739,774 662,198
Other expense (3,586) (47,794) (340)
Interest expense (48,690) (48,641) (56,839)
Interest income 22,058 38,807 36,078
Income before income taxes 678,239 682,146 641,097
Provision for income taxes 86,041 88,352 620,786
Net income $ 592,198 $ 593,794 $ 20,311
Net income per basic common share $ 8.76 $ 7.71 $ 0.25
Weighted-average number of basic common shares 67,627 76,992 79,793
Net income per diluted common share $ 8.69 $ 7.65 $ 0.25
Weighted-average number of diluted common shares and equivalents 68,166 77,618 80,604
Product [Member]      
Revenues:      
Total net sales $ 1,567,189 $ 1,604,993 $ 1,552,349
Costs and operating expenses:      
Costs and operating expenses 642,706 656,275 623,214
Service [Member]      
Revenues:      
Total net sales 839,407 814,936 756,729
Costs and operating expenses:      
Costs and operating expenses $ 367,994 $ 336,289 $ 323,853